Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Innate immunity serves as the first line of defence against invading pathogens such as bacteria and viruses. Toll-like receptors (TLRs) are examples of innate immune receptors, which sense specific molecular patterns from pathogens and activate immune responses. TLR9 recognizes bacterial and viral DNA containing the cytosine-phosphate-guanine (CpG) dideoxynucleotide motif. The molecular basis by which CpG-containing DNA (CpG-DNA) elicits immunostimulatory activity via TLR9 remains to be elucidated. Here we show the crystal structures of three forms of TLR9: unliganded, bound to agonistic CpG-DNA, and bound to inhibitory DNA (iDNA). Agonistic-CpG-DNA-bound TLR9 formed a symmetric TLR9-CpG-DNA complex with 2:2 stoichiometry, whereas iDNA-bound TLR9 was a monomer. CpG-DNA was recognized by both protomers in the dimer, in particular by the amino-terminal fragment (LRRNT-LRR10) from one protomer and the carboxy-terminal fragment (LRR20-LRR22) from the other. The iDNA, which formed a stem-loop structure suitable for binding by intramolecular base pairing, bound to the concave surface from LRR2-LRR10. This structure serves as an important basis for improving our understanding of the functional mechanisms of TLR9.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Structural studies recently described two different TLR9i sequences that formed stem-loop structures that fit snugly into the interior of the ring structure of TLR9, preventing dimerization and activation (21).”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [21]
In the citing paper
“the binding site of TLR9i oligonucleotides on TLR9 partially overlapped with that of CpG DNA, and the TLR9i oligonucleotide tested possessed higher binding affinity for TLR9 than CpG DNA”
From Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses (2021) · cites this paper as [21]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Schuck, P. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76713-0 · Cited by 3,868
Cited by
Items 301–381 of 381
Лушпа, В. А., Lin, C., Talyzina, I. A., Goncharuk, M. V., Bocharov, E. V., Arseniev, A. S., Wang, X., Goncharuk, S. A., & Mineev, K. S. (2025) · FEBS Letters · doi:10.1002/1873-3468.70026 · Cited by 3
Molecular Mechanisms of Innate Immune Sensing of Exogenous RNAs
Sioud, M. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4742-4_2 · Cited by 3
Shi, Y.-W., Li, L., & Chen, G. (2025) · Advanced Materials · doi:10.1002/adma.202509881 · Cited by 1
Hinata, D., Kai, Y., Fukuda, R., Kamada, Y., Kasahara, Y., Sasaki, K., Yoshida, T., Obika, S., Inoué, T., & Okiyoneda, T. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102756 · Cited by 2
“Among the ASO sequences complementary to the extracted regions, ASO candidates with toxic risk motif sequences such as TCC, TGC, 28 and unmethylated cytosine-phosphate-guanine (CpG) motifs 29 were eliminated.”
Chen, J., Su, M., Yu, B., Yang, M., Wang, H., Yang, X. L., & Wang, J. (2026) · Science Advances · doi:10.1126/sciadv.aeb2465 · Cited by 3
“For decades, the pursuit of TLR9 agonism has been dominated by the chemistry of nucleic acids ( 40 ).”
Mitochondrial DNA regulation of hepatic ischemia-reperfusion injury and intervention strategies
Shen, R., An, P., Chen, M., Lu, P., Yang, J., Wu, L., & Wang, R. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08155-5 · Cited by 2
“When mtDNA binds to TLR9 as stimulatory CpG-DNA, it forms a stable 2:2 symmetric complex, in which CpG-DNA is rapidly recognized by the N-terminal and C-terminal fragments of the dimer, thereby activating downstream signaling pathways [154].”
Cell type-specific role of Raftlin in the regulation of endosomal TLR signaling
(2016) · Inflammation and Cell Signaling · doi:10.14800/ics.1326 · Cited by 2
Clinical and Ocular Inflammatory Inhibitors of Viral-Based Gene Therapy of the Retina
Ohlhausen, M. E., & Conrady, C. D. (2024) · Acta Microbiologica Hellenica · doi:10.3390/amh69030018 · Cited by 2
Synergistic Activation of TLR7 and 8 Mediated by Reduction of Electrostatic Repulsion
Ekimoto, T., Nomura, M., Saito, Y. A., Suzuki, M., Yamane, T., Zhang, Z., Ohto, U., Ikeguchi, M., & Shimizu, T. (2024) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c24-00409 · Cited by 2
Self-citationExpansion of B10 cells in vitro: Pathways, techniques and applications in transplantation (Review)
Zhao, D., Huai, G., Yuan, Y., Cui, Y., Yuan, Y., & Zhao, G. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5470 · Cited by 3
“As a non‑ligand crystal, TLR9 can bind CpG‑DNA (44).”
Wang, Y., Bao, L., Liu, M., Tang, X., Liu, H., Liang, X., & Liu, Y. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303340093241227094242 · Cited by 3
Polyvalent Nucleic Acid Nanoprobes for Cancer Diagnosis and Therapy
Ma, W., Li, J., Zhang, H., Quan, K., Lei, Y., Yang, L., Wu, L., & Qing, Z. (2025) · Chemistry - A European Journal · doi:10.1002/chem.202404760 · Cited by 2
The Emerging Potential for Epigenetic Therapeutics in Noncancer Disorders
Bell, C. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00017-5 · Cited by 2
Miyamoto, N., Mochizuki, S., & Sakurai, K. (2019) · ACS symposium series · doi:10.1021/bk-2019-1309.ch004 · Cited by 2
The role of toll like receptor 9 in maintaining gut homeostasis
Varga Matthew, G., & Lin Henry, C. (2020) · Annals of Systems Biology · doi:10.17352/asb.000005 · Cited by 3
“Multiple hypotheses have been proposed, including the detection of hypomethylated CpG motifs [28], (as DNA methylation occurs only on cytosine in eukaryotes [29], but primarily, on adenine in prokaryotes [30], the specifi city of cellular uptake of select DNA molecules which are not degraded by host DNases [31], the s…”
BackgroundMironov, I. V., Гордиенко, А. В., Chumak, B. A., & Lvov, N. I. (2022) · Медико-фармацевтический журнал «Пульс» · doi:10.26787/nydha-2686-6838-2022-24-5-114-121 · Cited by 2
Khan, A. W., Qayyum, N., Manan, A., Farooq, M., Haseeb, M., Ilyas, S., Kim, W., & Choi, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149468 · Cited by 1
Inhalable DNA nano-adjuvant elicits robust lung-resident memory immunity against pneumonic plague
Fu, S., Li, Z., Yin, Z., Zhang, X. Z., Song, X., Hu, L., Zhou, D., Su, X., & Dai, C. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124009 · Cited by 1
Cutaneous-Tropism Viruses: Unraveling Pathogenetic Mechanisms and Immunoprophylactic Strategies
Lupoae, M., Elisei, A. M., Iacob, A. D., Lupoae, A., Tatu, A. L., Niculeț, E., Căuș, M. N., Batir, D. M., Nechita, A., Matei, M. N., et al. (2026) · Life · doi:10.3390/life16010174 · Cited by 1
Engineering the cartilage niche: Mimicking the microenvironment for functional outcomes
Talouki, P. Y., Tamimi, R., & Mahmoodi, M. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103405 · Cited by 3
G‐Quadruplex‐Modular CpG Nanoplatform Drives Multi‐Pathway Immunity for Abscopal Chemoimmunotherapy
Sun, M., Feng, H., Sun, X., Bai, R., Feng, F., Li, Q., Sun, H., & Yao, L. (2026) · Advanced Materials · doi:10.1002/adma.72908 · Cited by 1
“The well-established CpG ODN 2006-PD, containing three GTCGTT motifs, elicits robust immunostimulatory effects [ 27, 28 ].”
Strategies for Evading Cellular Immunity Against Recombinant AAV Vectors in Gene Therapy
Wang, Z., Wu, X., Fu, D.-Y., Li, X., Liu, D., Liu, S., Zhao, Q., & Wang, H. (2026) · Current Medical Science · doi:10.1007/s11596-026-00178-9 · Cited by 2
Chi, H., An, K., He, J., Du, Y., Yang, S., Wang, Y., Liu, X., Li, Y., Shu, M., Zheng, M., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01652-4 · Cited by 2
Baaziz, S., Alpaslan, M. K., Poyraz, E. B., Hannachi, B., Boutobba, Z., Falek, W., Benali-Cherif, R., Dege, N., Bendeif, E., & Benali-Chérif, N. (2026) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-026-03491-1 · Cited by 1
“Previous efforts to target TLR9 with synthetic ligands faced similar structural limitations [39].”
Innate Immunity of Framework Nucleic Acids
Guo, L., Zhou, F., Zhu, Y. J., Li, J., & Fan, C. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00246 · Cited by 2
Mechanism of Mitochondrial Transcription Factor A Attenuation of CpG-Induced Antibody Production
Malarkey, C. S., Gustafson, C. E., Saifee, J., Torres, R. M., Churchill, M. E. A., & Janoff, E. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157157 · Cited by 1
Jinno, M., Isomura, M., Sato, N., Torii, Y., Yoshida, W., Sugita, Y., Kubo, K., & Maeda, H. (2017) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.26.127 · Cited by 1
Imbalance in the ratio of CpG and polyG contributes to impaired interferon‐α expression
Lv, S., Li, S., Wang, Z., & Xia, J. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25419 · Cited by 1
Nucleic Acid Innate Immune Receptors
Saitoh, S.-I., & Miyake, K. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015714-00292 · Cited by 3
Self-citationPathophysiological functions of self-derived DNA
Ori, D., & Kawai, T. (2022) · International Reviews of Immunology · doi:10.1080/08830185.2022.2070616 · Cited by 1
Unconventional functions of miRNAs
Bosisio, D., Gaudenzi, C., Sozzani, S., & Salvi, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00011-x · Cited by 2
Genetic diversity of Toll‐like receptor 9 in swamp eels (Monopterus albus)
Huo, C., Tian, H., Rao, H., Zeng, B., Li, D., Li, Z., & Li, Y. (2023) · Journal of Fish Biology · doi:10.1111/jfb.15366 · Cited by 1
Nanushaj, D., Kono, M., Sakatani, H., Murakami, D., & Hotomi, M. (2023) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.23-0001 · Cited by 1
Construction of pVAX-1-based linear covalently closed vector with improved transgene expression
Vijayakumar, K. K., Manoharan, D., Subbarayan, R., Shrestha, R., & Shakila, H. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09856-0 · Cited by 1
“Similarly, unmethylated cyto-sine-phosphate-guanine (CpG) domains in plasmids can be recognized by the mammalian immune system via Toll-Like Receptor-9 (TRL-9), leading to unwanted inflammation and cell death [16, 17].”
Лушпа, В. А., Goncharuk, M. V., Arseniev, A. S., Mineev, K. S., & Goncharuk, S. A. (2025) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162024606670 · Cited by 1
Hoshi, K. (2025) · Journal of Structural Biology · doi:10.1016/j.jsb.2025.108252 · Cited by 1
Smith, R. M., Kotzé, A., Grobler, J. P., & Dalton, D. L. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.104118 · Cited by 1
Co-evolutionary analysis suggests a role for TLR9 in papillomavirus restrictionPreprint
King, K. M., Larsen, B. B., Gryseels, S., Richet, C., Kraberger, S. J., Jackson, R., Worobey, M., Harrison, J. S., Varsani, A., & Doorslaer, K. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.17.440006 · Cited by 1
“Figure 6 Yangochiroptera TLR9 is evolving under diversifying selection (A) Structure of horse TLR9 in complex with agonistic DNA (PDB: 3WPC) (Ohto et al. 2015).”
Nucleic Acid Recognition Mechanisms by Toll-Like Receptors
Ohto, U., & Shimizu, T. (2016) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.54.318
Self-citationDesign of antisense oligonucleotides
Obika, S., & Kasahara, Y. (2016) · Folia Pharmacologica Japonica · doi:10.1254/fpj.148.100
Roch, T., Hahne, S., Kratz, K. L., Ma, N., & Lendlein, A. (2017) · Biotechnology Journal · doi:10.1002/biot.201700334 · Cited by 1
Sauter, I. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2018.tde-15032018-121625
Dey, D., Dhar, D., Das, S., Maulik, A., & Basu, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/592626
Chemical Approaches for RNAi Drug Development
Saito–Tarashima, N. (2020) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.20-00157
Cai, S., Li, J., & Zhang, X. (2021) · Research Square · doi:10.21203/rs.3.rs-280189/v1 · Cited by 1
Golenkina, E. A., Galkina, S. I., Dolinnaya, N. G., Arifulin, E. A., Romanova, Y. M., & Sud’ina, G. F. (2021) · Pathogens · doi:10.3390/pathogens10050530
Bryant, C. E., & Boyle, J. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00204-2
Activation and Functions of Plasmacytoid Dendritic Cells
Ganguly, D. (2022) · Springer eBooks · doi:10.1007/978-981-19-5595-2_3
Gautam, H., Verma, V. V., Husain, S. A., & Bharadwaj, M. (2023) · Systems Biology in Reproductive Medicine · doi:10.1080/19396368.2022.2148837
“1 and TLR9 from Equus caballus (PDB ID: 3WPB) as templates (Ohto et al. 2015).”
Development of smart optical nanoagents for cancer immunotheranostics
Xu, C. (2024) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/179290 · Cited by 1
Takkouche, A., Ichii, K., Qiu, X.-R., Jaroszewski, L., & Godzik, A. (2025) · bioRxiv · doi:10.1101/2024.09.30.615863
Small-Molecule Modulators of Toll-Like Receptor Signaling and Their Clinical Applications
Matsunaga, N. (2024) · Premier journal of science. · doi:10.70389/pjs.100031 · Cited by 1
Structural Biology of Innate Immune Recognition
Han, Y., & Zhang, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00126-5
Chen, H., Kaneko, N., Ohyama, Y., & Moriyama, M. (2026) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103521 · Cited by 2
Patel, J., Yang, Z., Ping, S., Ahmed, A., Simon, T. W., Waggoner, J. J., & Scherer, E. M. (2026) · Journal of Virology · doi:10.1128/jvi.02150-25
“Only one cyclic dinucleotide molecule is required to activate each STING dimer to oligomerize (54, 55); AIM2 oligomerizes along a single dsDNA molecule (56); and two CpG molecules activate a TLR9 dimer (57).”
Discovery of Triazine-Based Toll-Like Receptor 9 Antagonists with Oral Activity
Mandler, M. D., Zhu, Y., Hollenbeck, E. C., Ziegler, M., Posy, S., Mukundan, S., Halpern, O. S., Driscoll, J. P., Wang, T., Huang, L., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00760
Grass, V. (2018) · theses.fr (ABES) · doi:10.70675/3b10422cz9bf4z4f02z81dczcf237dc03a18
Il-26 : une cytokine pro-inflammatoire stimulant les cellules immunitaires innées myéloïdes
Poli, C. (2017) · theses.fr (ABES) · doi:10.70675/154b0002zc293z47a9z8bfbz9909e15c15e6
Modulation de l'autophagie des macrophages : rôle des lipides de l'enveloppe
Bah, A. (2017) · theses.fr (ABES) · doi:10.70675/0170380fz0af5z4c02za7aezd5ac5153ffd8
Picard, L. (2020) · theses.fr (ABES) · doi:10.70675/af3af45az8c5fz4042zbf44z74b33801d49f · Cited by 1
Étude de la fonction de la DNASE1L3 en contexte auto-immun et anti-tumoral
Santa, P. (2024) · theses.fr (ABES) · doi:10.70675/2af1f0cfz45caz418azb93ez88367c4a54c8
Engineering polymeric RNA scaffolds as programmable combinatorial innate immune agonists
Yang, Y. Z., Alvarez, A. K., Wang, W., Issa, E. C., Dorsey, E., & Wu, C. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag328
“…of a DNA origami scaffold, a spacing of 3.5 nm, which approximates the distance between two CpG-DNA molecules binding to dimeric TLR9 in a crystal structure [ 67 ], exhibited the greatest potency as an in situ cancer vaccine, while a 7 nm spacing showed similar effects as random spacing [ 15 ].”
InfluentialRational design of topology-defined DNA nanoframeworks for antigen delivery and cross-presentation
Cao, Y., Wu, Y., Huang, X., Huang, K., Maj, T., Xu, Z., Sun, J., Shi, Q., & Yang, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04539-3
“3B) [36–38].”
Aptamer-based technologies for theranostics of central nervous system disorders
Ravichandran, K., Pal, S., & Ikezu, T. (2026) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2026-0009
“Computational scanning for CpG motifs and immunostimulatory sequence features has been incorporated into oligonucleotide design tools for antisense and siRNA therapeutics, and similar motif–structure accessibility analyses can be adapted for aptamer sequences [121].”
Velasquez-Esparza, M. M., López-Velázquez, R., Cázares-Preciado, A., Miranda-Roblero, H. O., Pérez-Treviño, P., Guerrero-Beltrán, C. E., & García, N. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_805
Patterned Structural Polymers: Advances and Perspectives
Ziyue, A. N., Wantong, S. O. N. G., & Chen, X. (2026) · China basic science · doi:10.3724/cbs.202602008
Kóšiová, I., Štěpánek, I., Šimák, O., Kostov, O., Petrová, M., Páv, O., Rejman, D., Liboska, R., Buděšı́nský, M., Rosenbergová, Š., et al. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00326
Sasidharan, S., Gosu, V., & Shin, D. (2026) · iScience · doi:10.1016/j.isci.2026.117060
“24,25 Crystal structures of Equus caballus TLR9 show that two receptor ectodomains bind two DNA ligands to form the active complex, and this architecture is highly relevant to human TLR9 given the >80% sequence conservation in the ligand-binding and dimerization regions ligands.”
Targeting toll-like receptors in the immunotherapy era: the chemistry behind TLR modulators
Mínguez-Toral, M., Fernández-Vasco, G., Furjun, A. B., Matamoros‐Recio, A., Martín-Cámara, O., & Martín‐Santamaría, S. (2026) · Chemical Society Reviews · doi:10.1039/d6cs00494f
Du, J., Liu, J., Chen, S., Deng, H., Ye, H., Xiao, X., Yang, J., Yang, J., Zhang, Z., Yin, T., et al. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103558
“The extracellular domain of TLR9 consists of leucine-rich repeat (LRR) motifs, which are responsible for the specific recognition of unmethylated CpG motifs in cfDNA, providing a structural basis that makes TLR9 an ideal target for cfDNA capture [30].”
Hu, B., Gutty, V. S. R., Herzog, R. W., & Duan, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1930231
“The ODN repeat sequence TTAGGG, commonly found in mammalian telomeres, has been shown to inhibit TLR9 dimerization and downstream signaling (151–153).”
Examination of the Immunological Role of Toll-Like Receptor 9 on Red Blood Cells
Oatman, E., Sayegh, L., & Mangalmurti, N. S. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5376-0_37
Zhu, X., Ge, J., Weng, C., Ning, Q., Qi, Y., Ding, S., Liang, H., Jing, B., Chen, X., Cheng, S., et al. (2026) · Engineering · doi:10.1016/j.eng.2026.09.005
Chen, H., Zhou, H., Jin, T., Zhang, Z., Zhao, Z., Cai, H., Yu, X., Liu, H., Chen, S., Li, C., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c17839
Li, Y., Sun, W., Liu, X., Hu, Z., Li, Y., Jin, X., & Zhu, X. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117566
BindingDB (2020) · UC San Diego · doi:10.7270/q2c2504d
BindingDB (2019) · UC San Diego · doi:10.7270/q2057jcj
Metadata
- Authors
- Ohto, U., Shibata, T., Tanji, H., Ishida, H., Krayukhina, E., Uchiyama, S., Miyake, K., & Shimizu, T.
- Affiliations
- The University of Tokyo (JP)
- Japan Science and Technology Agency (JP)
- The University of Osaka (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Shimizu, Toshiyuki
- Venue
- Nature
- Published
- 2015-02-09
- Volume
- 520
- Issue
- 7549
- Pages
- 702-705
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2129961630
- Semantic Scholar
- 385253b727f67c70b401c7d39f56cdcb8ddf5dc1
- Cited by
- 377
- References
- 34
- Citations by year
- 2026: 30 · 2025: 30 · 2024: 32 · 2023: 36 · 2022: 33 · 2021: 31 · 2020: 33 · 2019: 28 · 2018: 36 · 2017: 30 · 2016: 43 · 2015: 15
- FWCI
- 20.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (25121722, 25253032, 25291010)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- TLR9, CpG DNA, innate immunity, TLR9 activation, crystal structure, ligand binding, leucine-rich repeats, stem-loop structure, intramolecular base pairing
- MeSH terms
- Animals, Base Sequence, DNA, Humans, Ligands, Models, Molecular, Nucleic Acid Conformation, Structure-Activity Relationship, Protein Structure, Tertiary, Crystallography, X-Ray, CpG Islands, Toll-Like Receptor 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.